Tracing the incidence of paclitaxel-induced peripheral neuropathy

被引:2
作者
Argyriou, A. A. [1 ]
机构
[1] St Andrews State Gen Hosp Patras, Dept Neurol, Patras 26335, Greece
关键词
CHEMOTHERAPY; NEUROTOXICITY; CANCER;
D O I
10.1111/j.1365-2354.2009.01140.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:522 / 523
页数:2
相关论文
共 7 条
[1]   Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy [J].
Argyriou, A. A. ;
Polychronopoulos, P. ;
Koutras, A. ;
Xiros, N. ;
Petsas, T. ;
Argyriou, K. ;
Kalofonos, H. P. ;
Chroni, E. .
EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (03) :231-237
[2]   Peripheral nerve damage associated with administration of taxanes in patients with cancer [J].
Argyriou, Andreas A. ;
Koltzenburg, Martin ;
Polychronopoulos, Panagiotis ;
Papapetropoulos, Spiridon ;
Kalofonos, Haralabos P. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (03) :218-228
[3]   The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale [J].
Cavaletti, Guido ;
Frigeni, Barbara ;
Lanzani, Francesca ;
Piatti, Marialuisa ;
Rota, Stefania ;
Briani, Chiara ;
Zara, Gabriella ;
Plasmati, Rosaria ;
Pastorelli, Francesca ;
Caraceni, Augusto ;
Pace, Andrea ;
Manicone, Marlagrazia ;
Lissoni, Andrea ;
Colombo, Nicoletta ;
Blanchi, Giulia ;
Zanna, Claudio .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (03) :210-215
[4]   Physician and patient-oriented outcomes in progressive neurological disease: Which to measure? [J].
Hobart, JC ;
Freeman, JA ;
Lamping, DL .
CURRENT OPINION IN NEUROLOGY, 1996, 9 (06) :441-444
[5]   Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel [J].
Loven, D. ;
Levavi, H. ;
Sabach, G. ;
Zart, R. ;
Andras, M. ;
Fishman, A. ;
Karmon, Y. ;
Levi, T. ;
Dabby, R. ;
Gadoth, N. .
EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (01) :78-83
[6]   Grading of chemotherapy-induced peripheral neuropathy [J].
Postma, TJ ;
Heimans, JJ .
ANNALS OF ONCOLOGY, 2000, 11 (05) :509-513
[7]   How to assess new drugs for neuropathies: advances in trial design and methodology [J].
van Doorn, Pieter A. ;
Merkies, Ingemar S. J. .
CURRENT OPINION IN NEUROLOGY, 2008, 21 (05) :519-526